A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors.

MLA

Reis, Henning, et al. “A Structured Proteomic Approach Identifies 14-3-3Sigma as a Novel and Reliable Protein Biomarker in Panel Based Differential Diagnostics of Liver Tumors.” Biochimica et Biophysica Acta, vol. 1854, no. 6, June 2015, pp. 641–50. EBSCOhost, https://doi.org/10.1016/j.bbapap.2014.10.024.

APA

Reis, H., Pütter, C., Megger, D. A., Bracht, T., Weber, F., Hoffmann, A.-C., Bertram, S., Wohlschläger, J., Hagemann, S., Eisenacher, M., Scherag, A., Schlaak, J. F., Canbay, A., Meyer, H. E., Sitek, B., & Baba, H. A. (2015). A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors. Biochimica et Biophysica Acta, 1854(6), 641–650. https://doi.org/10.1016/j.bbapap.2014.10.024

Chicago

Reis, Henning, Carolin Pütter, Dominik A Megger, Thilo Bracht, Frank Weber, Andreas-C Hoffmann, Stefanie Bertram, et al. 2015. “A Structured Proteomic Approach Identifies 14-3-3Sigma as a Novel and Reliable Protein Biomarker in Panel Based Differential Diagnostics of Liver Tumors.” Biochimica et Biophysica Acta 1854 (6): 641–50. doi:10.1016/j.bbapap.2014.10.024.